Ampio Pharmaceuticals (NYSE:AMPE) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a report released on Friday morning. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Performance

Shares of NYSE:AMPE opened at $0.00 on Friday. The firm has a market capitalization of $2,508.00, a P/E ratio of 0.00 and a beta of 3.73. Ampio Pharmaceuticals has a 52 week low of $0.00 and a 52 week high of $7.47.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.